Equity Cure Right Friction
The Formal Definition
A structural loan covenant clause in corporate credit facilities allowing a company's private equity sponsor or shareholders to inject fresh equity capital to cure financial ratio breaches (such as leverage or interest coverage covenants), artificially preventing technical loan defaults.
Adjusted EBITDA for Compliance = Operating EBITDA + Direct Cash Equity Cure Contribution
Cole Barrett's Reality Check
The Unvarnished Bottom Line"An equity cure is an accounting defibrillator for private equity debt. When a leveraged company is about to breach its debt covenants because earnings collapsed, the private equity sponsor injects $5 million in fresh equity and adds it directly to EBITDA. It's pure financial alchemy: it doesn't change business operations, but it resets the covenant math and keeps the bank from foreclosing."
Interactive Simulator: Test the Math
Real-World Example: Scenario Breakdown
Examining the real numbers for: A leveraged middle-market company with $50,000,000 in bank debt facing an imminent leverage covenant default
| Execution Metric | Private Equity Sponsor (Cure Exerciser) | Senior Bank Syndicate Lender |
|---|---|---|
| Fee / Rate | Corporate treasury transfer | Loan management fee |
| Spread / Buffer | Company EBITDA fell to $9M (breaching the 5.0x Max Leverage covenant on $50M debt; actual = 5.55x) | Anticipated declaring a default to seize company assets and renegotiate interest rate margins higher |
| Execution / Status | Sponsor executed an Equity Cure: injected $1,500,000 in cash, adding it directly to calculated compliance EBITDA | Sponsor exercised contractual equity cure rights; bank was legally barred from declaring technical default |
| Total Cost / Result | Preserved company control and prevented bank acceleration via equity cure | Blocked from taking remedial enforcement actions by equity cure terms |
How Brokers Weaponize This Term
When analyzing syndicated loans or Business Development Company (BDC) credit portfolios, check the 'Covenant Compliance' footnotes. If a borrower relies on recurring 'Equity Cures' to pass leverage tests, the underlying business is distressed and burning cash.
Broker Evaluation Matrix
Cole Approves
Charles Schwab: Provides institutional research on public BDC loan portfolios, tracking non-accruals, credit amendments, and borrower covenant waivers.
Read Audit →Cole Flags / Avoids
Unregulated Private Debt Portals: Markets private loan notes that permit unlimited equity cures, masking borrower operational distress from retail investors.
View Trap Details →Frequently Asked Questions
How many times can an equity cure be used?
Standard institutional credit agreements restrict equity cures to no more than two consecutive quarters and no more than four or five times over the life of a loan.
Does equity cure cash have to be used to pay down the debt?
Not always. Some credit agreements allow the cash to remain on the balance sheet as working capital, while others mandate an immediate pro-rata repayment of outstanding senior loans.